288 related articles for article (PubMed ID: 17986722)
1. Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costs.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Invasive Cardiol; 2007 Nov; 19(11):469-75. PubMed ID: 17986722
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.
Magnuson EA; Farkouh ME; Fuster V; Wang K; Vilain K; Li H; Appelwick J; Muratov V; Sleeper LA; Boineau R; Abdallah M; Cohen DJ;
Circulation; 2013 Feb; 127(7):820-31. PubMed ID: 23277307
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.
Krenn L; Kopp C; Glogar D; Lang IM; Delle-Karth G; Neunteufl T; Kreiner G; Kaider A; Bergler-Klein J; Khorsand A; Nikfardjam M; Laufer G; Maurer G; Gyöngyösi M
Catheter Cardiovasc Interv; 2014 Dec; 84(7):1029-39. PubMed ID: 24403120
[TBL] [Abstract][Full Text] [Related]
5. Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.
Cohen DJ; Lavelle TA; Van Hout B; Li H; Lei Y; Robertus K; Pinto D; Magnuson EA; Mcgarry TF; Lucas SK; Horwitz PA; Henry CA; Serruys PW; Mohr FW; Kappetein AP
Catheter Cardiovasc Interv; 2012 Feb; 79(2):198-209. PubMed ID: 21542113
[TBL] [Abstract][Full Text] [Related]
6. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
7. [Can PCI with drug-eluting stents replace coronary artery bypass surgery? A comparative economic analysis regarding both therapeutic options based on clinical 12-month data reflecting the German social health care insurance system].
Fricke FU; Silber S
Herz; 2005 Jun; 30(4):332-8. PubMed ID: 15965811
[TBL] [Abstract][Full Text] [Related]
8. Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease.
Shimizu T; Ohno T; Ando J; Fujita H; Nagai R; Motomura N; Ono M; Kyo S; Takamoto S
Circ J; 2010 Mar; 74(3):449-55. PubMed ID: 20075560
[TBL] [Abstract][Full Text] [Related]
9. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
10. Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.
Birim Ö; Bogers AJ; Kappetein AP
J Cardiovasc Surg (Torino); 2012 Oct; 53(5):641-50. PubMed ID: 22252542
[TBL] [Abstract][Full Text] [Related]
11. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention with drug-eluting stent implantation vs. coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction.
Ahmed K; Jeong MH; Chakraborty R; Hong YJ; Sim DS; Hwang SH; Lee MG; Park KH; Kim JH; Ahn Y; Cho MC; Kim CJ; Kim YJ; Park JC; Kang JC;
Circ J; 2012; 76(3):721-8. PubMed ID: 22240598
[TBL] [Abstract][Full Text] [Related]
13. Cost of single-vessel and multivessel coronary drug-eluting stenting: comparison to the DRG funding level.
Varani E; Balducelli M; Gatti C; Tesselli MR; Vecchi G; Maresta A
Ital Heart J; 2005 Jan; 6(1):52-8. PubMed ID: 15773274
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
[TBL] [Abstract][Full Text] [Related]
15. Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease.
Qiao Y; Ma C; Nie S; Liu X; Kang J; Lv Q; Du X; Hu R; Zhang Y; Jia C; Liu X; Dong J; Chen F; Zhou Y; Lv S; Huang F; Gu C; Wu X
Clin Cardiol; 2009 Aug; 32(8):E24-30. PubMed ID: 19455692
[TBL] [Abstract][Full Text] [Related]
16. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
[TBL] [Abstract][Full Text] [Related]
18. PCI versus CABG for multivessel coronary disease in diabetics.
Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
[TBL] [Abstract][Full Text] [Related]
20. Propensity score-matched analysis of coronary artery bypass grafting versus second-generation drug-eluting stents for triple-vessel disease.
Nishigawa K; Fukui T; Hagiya K; Tobaru T; Uemura K; Takanashi S
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1152-1159. PubMed ID: 30561571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
